Navigation
Home covid-19 health WHO WHO pauses hydroxychloroquine trial over safety concerns

WHO pauses hydroxychloroquine trial over safety concerns

WHO pauses hydroxychloroquine trial over safety concerns
May 26, 2020 Excelsio Media
Share To:
The World Health Organization said that it has suspended its trial of the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns.

Share
Tags covid-19 health WHO

Excelsio Media

EXCELSIO Media, is an independent source of news and information.

View Profile
covid-19 health WHO

Post A Comment:

0 comments:

Leave a comment. Thanks!

Subscribe to: Post Comments (Atom)